Logotype for Relaxo Footwears Limited

Relaxo Footwears (RELAXO) Q4 24/25 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Relaxo Footwears Limited

Q4 24/25 earnings summary

8 Jul, 2026

Executive summary

  • FY25 revenue was INR 2,914.06 crore, down 4.3% year-over-year, with Q4 FY25 revenue at INR 703.24 crore, mainly due to softer volumes in the mid-range and economy segments.

  • Net profit for FY25 was INR 170.33 crore, a 15% decline year-over-year; Q4 FY25 PAT at INR 56.22 crore, down 8.4% from Q4 FY24.

  • EBITDA margin for FY25 stood at 13.7%, slightly lower than FY24's 13.95%.

  • The company remains net debt-free, with investments of INR 3.57 billion as of March 31, 2025, and capex of INR 114.90 crore.

  • Audited financial results for FY25 were approved with an unmodified audit opinion from statutory auditors.

Financial highlights

  • FY25 EBIT at INR 229.9 crore (8.2% margin), down from INR 269.3 crore (9.2%) in FY24.

  • Gross margin for Q4 was 64.9%, down from 60.3% last year, impacted by inventory reduction and accounting effects.

  • Cash generated from operations in FY25 was INR 406.01 crore, up from INR 235.12 crore in FY24.

  • Basic EPS for FY25 was INR 6.84, down from INR 8.05 in FY24.

  • Capacity utilization stands at 55%.

Outlook and guidance

  • Management expects improvement in top-line and EBITDA margin in FY26, driven by operational efficiency and product mix.

  • Margin improvement of at least 100 basis points is targeted, supported by cost efficiencies and premium product launches.

  • ROCE expected to improve by 2-3% in coming years as EBIT and EBITDA rise.

  • Board recommended a final dividend of INR 3.00 per share (300% of face value), totaling INR 74.68 crore for FY25, subject to shareholder approval.

  • Indian footwear market expected to grow at a 10.1% CAGR through 2033, with the organised segment expanding faster than the overall industry.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more